Galera Therapeutics effects 1-for-200 reverse stock split; shares to trade under GRTXD on OTCQB

Galera Therapeutics, Inc.

Reverse stock split of common stock at 1:200 ratio effective July 12, 2026.
No fractional shares; stockholders receive cash value based on closing price prior to split.
Outstanding options and warrants adjusted proportionally with exercise price increases.
Common stock begins trading on OTCQB under ticker GRTXD on July 13, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.